CIK: 0001577524 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value ($000): $432,144 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 413,858 | $113,322 | 26.2% | $285.68 | +8.7% | COM | 09062X103 |
| — | MEDICINES CO | 1,922,000 | $63,310 | 14.7% | $29.43 | — | COM | 584688105 |
| INVA | INNOVIVA INC | 3,660,705 | $61,023 | 14.1% | $11.14 | +38.6% | COM | 45781M101 |
| — | ALLERGAN PLC | 344,000 | $57,891 | 13.4% | $164.77 | — | SHS | G0177J108 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 3,367,100 | $51,954 | 12.0% | $12.76 | -2.3% | COM CL A | 46333X108 |
| — | SHIRE PLC | 264,000 | $39,438 | 9.1% | $149.39 | — | SPONSORED ADR | 82481R106 |
| — | INTERCEPT PHARMACEUTICALS INC | 635,300 | $39,083 | 9.0% | $60.63 | — | COM | 45845P108 |
| — | NOVELION THERAPEUTICS INC | 1,025,000 | $3,587 | 0.8% | $8.42 | — | COM NEW | 67001K202 |
| — | ACHILLION PHARMACEUTICALS INC | 500,000 | $1,855 | 0.4% | $4.26 | — | COM | 00448Q201 |
| — | APRICUS BIOSCIENCES INC | 1,447,906 | $587 | 0.1% | $1.30 | — | COM NEW | 03832V307 |
| ABBV | ABBVIE INC | 1,000 | $94 | 0.0% | $38.85 | +102.2% | COM | 00287Y109 |